Literature for inhibitor I01.037: RECK protein inhibitor unit 1

(Topics flags: K Knockout. To select only the references relevant to a single topic, click the link above. See explanation.)

2026
1. Noda,M., Alexander,D. and Matsuzaki,T.
   The Roles of the Membrane-Anchored Glycoprotein RECK in Animal Development, Tumor Suppression, and Beyond
   Life (Basel) (2026) 16 PubMed  Europe PubMed DOI  PMC  EPMC
2021
2. Abo El-Khair,S.M., Elalfy,H., Diasty,M., Ebrahim,E.E. and Elsamanoudy,A.Z.
   Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients
   J Biochem Mol Toxicol (2021) , e22886-e22886. PubMed  Europe PubMed DOI
2009
3. Omura,A., Matsuzaki,T., Mio,K., Ogura,T., Yamamoto,M., Fujita,A., Okawa,K., Kitayama,H., Takahashi,C., Sato,C. and Noda,M.
   RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin
   J Biol Chem (2009) 284, 3461-3469. PubMed  Europe PubMed DOI
2008
4. Chang,C.K., Hung,W.C. and Chang,H.C.
   The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo
   J Cell Mol Med (2008) 12, 2781-2789. PubMed  Europe PubMed DOI
2007
5. Noda,M. and Takahashi,C.
   Recklessness as a hallmark of aggressive cancer
   Cancer Sci (2007) 98, 1659-1665. PubMed  Europe PubMed DOI
2006
6. [YEAR:29-11-2006]Song,S.Y., Son,H.J., Nam,E., Rhee,J.C. and Park,C.
   Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer
   Eur J Cancer (29-11-2006) 42, 101-108. PubMed  Europe PubMed DOI
2005
7. Takagi,S., Kato,Y., Asano,K., Ohsaki,T., Bosnakovski,D., Hoshino,Y., Okumura,M., Kadosawa,T. and Fujinaga,T.
   Matrix metalloproteinase inhibitor RECK expression in canine tumors
   J Vet Med Sci (2005) 67, 761-767. PubMed  Europe PubMed DOI
8. Takagi,S., Kitamura,T., Hosaka,Y., Ohsaki,T., Bosnakovski,D., Kadosawa,T., Okumura,M. and Fujinaga,T.
   Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK
   J Vet Med Sci (2005) 67, 385-391. PubMed  Europe PubMed DOI
9. [YEAR:4-11-2005]van Lent,P.L., Span,P.N., Sloetjes,A.W., Radstake,T.R., van Lieshout,A.W., Heuvel,J.J., Sweep,C.G. and van den Berg,W.B.
   Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis
   Ann Rheum Dis (4-11-2005) 64, 368-374. PubMed  Europe PubMed DOI  PMC  EPMC
2004
10. Chang,H.C., Liu,L.T. and Hung,W.C.
    Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK
    Cell Signal (2004) 16, 675-679. PubMed  Europe PubMed DOI
2003
11. [YEAR:15-6-2003]Liu,L.T., Chang,H.C., Chiang,L.C. and Hung,W.C.
    Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion
    Cancer Res (15-6-2003) 63, 3069-3072. PubMed  Europe PubMed
12. [YEAR:13-11-2003]Liu,L.T., Peng,J.P., Chang,H.C. and Hung,W.C.
    RECK is a target of Epstein-Barr virus latent membrane protein 1
    Oncogene (13-11-2003) 22, 8263-8270. PubMed  Europe PubMed DOI
13. Noda,M., Oh,J., Takahashi,R., Kondo,S., Kitayama,H. and Takahashi,C.
    RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling
    Cancer Metastasis Rev (2003) 22, 167-175. PubMed  Europe PubMed DOI
14. [YEAR:1-6-2003]Span,P.N., Sweep,C.G., Manders,P., Beex,L.V., Leppert,D. and Lindberg,R.L.
    Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma
    Cancer (1-6-2003) 97, 2710-2715. PubMed  Europe PubMed DOI
2002
15. [YEAR:28-11-2002]Liu,L.T., Chang,H.C., Chiang,L.C. and Hung,W.C.
    Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells
    Oncogene (28-11-2002) 21, 8347-8350. PubMed  Europe PubMed DOI
16. Rhee,J.S. and Coussens,L.M.
    RECKing MMP function: implications for cancer development
    Trends Cell Biol (2002) 12, 209-211. PubMed  Europe PubMed DOI  K
17. Takahashi,C., Junseo,O. and Noda,M.
    [The membrane-anchored metalloproteinase inhibitor RECK]
    Tanpakushitsu Kakusan Koso (2002) 47, 1889-1895. PubMed  Europe PubMed
18. Weaver,V.M.
    Membrane-associated MMP regulators: novel cell adhesion tumor suppressor proteins?
    Dev Cell (2002) 2, 6-7. PubMed  Europe PubMed DOI
19. [YEAR:19-3-2002]Welm,B., Mott,J. and Werb,Z.
    Developmental biology: vasculogenesis is a wreck without RECK
    Curr Biol (19-3-2002) 12, R209-R211. PubMed  Europe PubMed  K
2001
20. Furumoto,K., Arii,S., Mori,A., Furuyama,H., Gorrin Rivas,M.J., Nakao,T., Isobe,N., Murata,T., Takahashi,C., Noda,M. and Imamura,M.
    RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing - cysteine-rich protein with Kazal motifs
    Hepatology (2001) 33, 189-195. PubMed  Europe PubMed DOI
21. [YEAR:14-12-2001]Oh,J., Takahashi,R., Kondo,S., Mizoguchi,A., Adachi,E., Sasahara,R.M., Nishimura,S., Imamura,Y., Kitayama,H., Alexander,D.B., Ide,C., Horan,T.P., Arakawa,T., Yoshida,H., Nishikawa,S., Itoh,Y., Seiki,M., Itohara,S., Takahashi,C. and Noda,M.
    The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
    Cell (14-12-2001) 107, 789-800. PubMed  Europe PubMed DOI
1998
22. [YEAR:27-10-1998]Takahashi,C., Sheng,Z., Horan,T.P., Kitayama,H., Maki,M., Hitomi,K., Kitaura,Y., Takai,S., Sasahara,R.M., Horimoto,A., Ikawa,Y., Ratzkin,B.J., Arakawa,T. and Noda,M.
    Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
    Proc Natl Acad Sci U S A (27-10-1998) 95, 13221-13226. PubMed  Europe PubMed DOI  PMC  EPMC